Sinovac Biotech Ltd. (NASDAQ:SVA)

CAPS Rating: 2 out of 5

A biopharmaceutical company which is in the business of research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases.

Recs

0
Player Avatar pchop123 (78.58) Submitted: 12/19/2012 3:40:31 PM : Outperform Start Price: $2.70 SVA Score: +9.19

good buying opportunity now

Featured Broker Partners


Advertisement